Upstream Bio Inc (UPB)

Nov 21, 2024

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Manila Times

Nov 21, 2024

Nov 20, 2024

Upstream Bioprocessing Industry Analysis and Forecast, - GlobeNewswire

Nov 20, 2024

Nov 13, 2024

Upstream Bio, Inc.’s (NASDAQ:UPB) Quiet Period Set To End on November 20th - Defense World

Nov 13, 2024

Nov 13, 2024

Upstream Bio, Inc.'s (NASDAQ:UPB) Quiet Period Set To End on November 20th - MarketBeat

Nov 13, 2024

Nov 11, 2024

Brokers Set Expectations for Upstream Bio Q4 Earnings - MarketBeat

Nov 11, 2024

Nov 08, 2024

Upstream Bio Advances Clinical Trials, Strengthens Financials - TipRanks

Nov 08, 2024

Nov 08, 2024

Tezspire Phase III Nasal Polyp Data May Lead To Second Indication - Scrip

Nov 08, 2024

Nov 08, 2024

William Blair Weighs in on Upstream Bio Q4 Earnings - Defense World

Nov 08, 2024

Nov 07, 2024

Upstream Bio Inc (UPB) Quarterly 10-Q Report - Quartz

Nov 07, 2024

Nov 07, 2024

Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire

Nov 07, 2024

Nov 07, 2024

FMR LLC Acquires New Stake in Upstream Bio Inc - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Severe Asthma Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve

Nov 07, 2024

Nov 06, 2024

Upstream Bio initiated with an Overweight at Piper Sandler - MSN

Nov 06, 2024

Nov 06, 2024

Discover the 3 Best-Performing Biotech IPO Stocks of 2024 - MarketBeat

Nov 06, 2024

Nov 05, 2024

Here are Tuesday's biggest analyst calls: Apple, Microsoft, Palantir, Eli Lilly, Broadcom, Krispy Kreme, Live Nation & more - Head Topics

Nov 05, 2024

Nov 05, 2024

Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say - Benzinga

Nov 05, 2024

Nov 05, 2024

Upstream Bio initiated with an Overweight at JPMorgan - MSN

Nov 05, 2024

Nov 05, 2024

This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Nov 05, 2024

Nov 05, 2024

Piper Sandler Begins Coverage on Upstream Bio (NASDAQ:UPB) - MarketBeat

Nov 05, 2024

Nov 05, 2024

TD Cowen bullish on Upstream Bio, bets on differentiated asthma treatment verekitug - Investing.com

Nov 05, 2024

Nov 05, 2024

Piper Sandler sees big potential for Upstream Bio asthma therapy, Overweight on stock - Investing.com UK

Nov 05, 2024

Oct 26, 2024

Upstream Bio prices IPO at $17 per share - MSN

Oct 26, 2024

Oct 25, 2024

Finance Watch: Septerna Raises $288m In Public Market Debut - Citeline News & Insights

Oct 25, 2024

Oct 25, 2024

Septerna Shares Jump 19% After IPO Shows Biotech Still Hot - Bloomberg

Oct 25, 2024

Oct 25, 2024

CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs - MSN

Oct 25, 2024

Oct 24, 2024

Goldman-backed drug developer Septerna raises $288 mln in US IPO - Reuters

Oct 24, 2024

Oct 24, 2024

Upstream Bio stock rallies 32% following upsized $255M IPO - MSN

Oct 24, 2024

Oct 24, 2024

Upstream Bioprocessing Market Forecast 2024: Key Global Developments - openPR

Oct 24, 2024

Oct 23, 2024

Upstream Bio Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Oct 23, 2024

Oct 23, 2024

Upstream Bio Rings the Opening Bell - Nasdaq

Oct 23, 2024

Oct 20, 2024

Warren Buffett and Biotech IPOs Highlight Recent Insider Buying - 24/7 Wall St.

Oct 20, 2024

Oct 18, 2024

Insider Trading Recap: Thursday's Top Buys and Sells in US Stocks - Investing.com

Oct 18, 2024

Oct 18, 2024

OrbiMed Advisors LLC purchases $14 million in Upstream Bio shares - Investing.com India

Oct 18, 2024

Oct 17, 2024

Orbimed Advisors LLC Acquires New Stake in Upstream Bio Inc - Yahoo Finance

Oct 17, 2024

Oct 17, 2024

OrbiMed Advisors LLC purchases $14 million in Upstream Bio shares By Investing.com - Investing.com Nigeria

Oct 17, 2024

Oct 17, 2024

Upstream bio director Erez Chimovits buys $14 million in shares By Investing.com - Investing.com South Africa

Oct 17, 2024

Oct 17, 2024

Upstream bio director Erez Chimovits buys $14 million in shares - Investing.com

Oct 17, 2024

Oct 17, 2024

Some of the Major Key Players in the Continuous Bioprocessing Market are - InsightAce Analytic

Oct 17, 2024

Oct 16, 2024

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - The Manila Times

Oct 16, 2024

Oct 15, 2024

Chronic Rhinosinusitis with Nasal Polyps Market Expected - openPR

Oct 15, 2024

Oct 15, 2024

Upstream Bio and Camp4 and Ceribell Transactions - William Blair

Oct 15, 2024

Oct 14, 2024

Upstream Bio shares soar in impressive IPO - The Pharma Letter

Oct 14, 2024

Oct 14, 2024

Opening Day: Another trio of biotech IPOs make Friday debut - Yahoo Finance

Oct 14, 2024

Oct 14, 2024

HBM portfolio company Upstream Bio raises USD 255 million in successful initial public offering - Marketscreener.com

Oct 14, 2024

Oct 13, 2024

Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN

Oct 13, 2024